Colon cancer during pregnancy

Gastroenterology Clinics of North America

Volumn 32, Issue 1, 2003, Pages 341-383

  Cappell, Mitchell S ^a,b  

^a WOODHULL MEDICAL CENTER   (United States)

^b Downstate Health Sciences University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; METHOTREXATE; PETHIDINE;

ABORTION; ALOPECIA; ANOREXIA; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHILDBIRTH; CLEFT PALATE; CLINICAL FEATURE; CLINICAL TRIAL; COLON CANCER; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL MALFORMATION; CYANOSIS; DIARRHEA; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DRUG SAFETY; FETOTOXICITY; FETUS MONITORING; FETUS WASTAGE; FEVER; HISTOPATHOLOGY; HUMAN; LABORATORY DIAGNOSIS; LEUKOPENIA; MEGALOBLASTIC ANEMIA; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; NONHUMAN; ONCOGENE; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; PROGNOSIS; RECTUM HEMORRHAGE; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SIGMOIDOSCOPY; TERATOGENICITY; TRANSRECTAL ULTRASONOGRAPHY;

ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; COLONOSCOPY; DIAGNOSIS, DIFFERENTIAL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; RISK FACTORS;

EID: 0037334718     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(02)00066-3     Document Type: Review

References (323)

1. Balloni L, Pugliese P, Ferrari S, et al. Colon cancer in pregnancy: report of a case and review of the literature [letter]. Tumori 2000;86:95-7.
2. Komurcu S, Ozet A, Ozturk B, et al. Colon cancer during pregnancy: a case report. J Reprod Med 2001;46:75-8.
3. Skilling JS. Colorectal cancer complicating pregnancy. Obstet Gynecol Clin North Am 1998;25:417-21.
4. Mahowald MB. Maternal-fetal conflict: positions and principles. Clin Obstet Gynecol 1992;35:729-37.
5. Nelson LJ. Legal dimensions of maternal-fetal conflict. Clin Obstet Gynecol 1992;35:738-48.
6. Bernstein MA, Madoff RD, Caushaj PF. Colon and rectal cancer in pregnancy. Dis Colon Rectum 1993;36:172-8.
7. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
8. Eddy DM. Screening for colorectal cancer. Ann Intern Med 1990;113:373-84.
9. Cappell MS, Goldberg ES. The relationship between the clinical presentation and spread of colon cancer in 315 consecutive patients: a significant trend of earlier cancer detection from 1982 through 1988 at a university hospital. J Clin Gastroenterol 1992;14:227-35.
10. Cunningham FG, Gant NF, Levano KJ, et al. Neoplastic diseases: colorectal carcinoma. In: Williams obstetrics. 21st edition. New York: McGraw-Hill; 2001. p 1453.
11. Falterman KW, Hill CB, Markey JC, et al. 1. Cancer of the colon, rectum, and anus: a review of 2313 cases. Cancer 1974;34:951-9.
12. Isbister WH, Frasier J. Large-bowel cancer in the young: a national survival study. Dis Colon Rectum 1990;33:363-6.
13. Nesbitt JC, Moise KJ, Sawyers JL. Colorectal carcinoma in pregnancy. Arch Surg 1985;120:636-40.
14. McLean DW, Arminski TC, Bradley GT. Management of primary carcinoma of the rectum diagnosed during pregnancy. Am J Surg 1955;90:816-25.
15. Potter JF, Schoeneman M. Metastases of maternal cancer to the placenta and fetus. Cancer 1970;25:380-8.
16. Woods JB, Martin Jr. JN, Ingram FH, et al. Pregnancy complicated by carcinoma of the colon above the rectum. Am J Perinatol 1992;9:102-10.
17. Hansen JP. Older maternal age and pregnancy outcome: a review of the literature. Obstet Gynecol Surv 1986;41:726-42.
18. National Center for Health Statistics. US Department of Health and Human Services. Vital statistics of the United States 1989, vol. 1: natality. Washington (DC): US Government Printing Office; 1993.
19. Kitoh T, Nishimura S, Fukuda S, et al. The incidence of colorectal cancer during pregnancy in Japan: report of two cases and review of Japanese cases. Am J Perinatol 1998;15:165-71.
20. Ransohoff DF, Lang CA. Screening for colorectal cancer. N Engl J Med 1991;325:37-41.
21. Levin B, Raijman I. Malignant tumors of the colon and rectum. In: Haubrich WS, Schaffner F, Berk JE. Bockus' gastroenterology. 5th edition. Philadelphia: WB Saunders; 1995. p 1749.
22. Jarvinen HJ. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut 1992;33:357-60.
23. Burt RW. Familial risk and colorectal cancer. Gastrointest Clin North Am 1996;25:793-803.
24. Lanspa SJ, Lynch HT, Smyrk TC, et al. Colorectal adenomas in the Lynch syndromes: results of a colonoscopy screening program. Gastroenterology 1990;98:1117-22.
25. Itzkowitz SH. Inflammatory bowel disease and cancer. Gastroenterol Clin North Am 1997;26:129-39.
26. Girard RM, Lamarche J, Baillot R. Carcinoma of the colon associated with pregnancy: report of a case. Dis Colon Rectum 1981;24:473-5.
27. Burtness B. Neoplastic diseases. In: Burrow GN, Duffy TP, editors. Medical complications during pregnancy. 5th edition. Philadelphia: WB Saunders; 1999. p 469-94.
28. Ziegler RG, Devesa SS, Fraumeni JF. Epidemiologic patterns of colorectal cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Important advances in oncology, 1986. Philadelphia: JB Lippincott; 1986. p 209-31.
29. Bresalier RS, Kim YS. Malignant neoplasms of the large intestine. In: Sleissenger MH, Fordtran JS, Scharschmidt BF, et al, editors. Gastrointestinal and liver disease: pathophysiology, diagnosis, management. 6th editon. Philadelphia: WB Saunders; 1998. Pages 1906-42.
30. Sandler RS. Epidemiology and risk factors for colon cancer. Gastroenterol Clin North Am 1996;25:717-35.
31. Haenszel W, Kurihara M. Studies of Japanese immigrants: I. mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968;40:43-68.
32. Nomura A. An international search for causative factors of colorectal cancer. J Natl Cancer Inst 1990;82:894-5.
33. Chan YM, Ngai SW, Lao TT. Colon cancer in pregnancy: a case report. J Reprod Med 1999;44:733-6.
34. Sugarbaker PH. Clinical evaluation of symptomatic patients. In: Steele Jr. G, Osteen RT, editors. Colorectal cancer: current concepts in diagnosis and treatment. New York: Marcel Dekker; 1986. p 66.
35. Posner MC, Steele Jr. GD, Mayer RJ. Adenocarcinoma of the colon and rectum. In: Zuidema GD, editor. Shackelford's surgery of the alimentary tract. 5th edition. Philadelphia: WB Saunders; 2002. p 219-36.
36. Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med 1994;329:1691-5.
37. Theologides A. Cancer cachexia. Cancer 1979;43:2004-12.
38. Bentley DP. Iron metabolism and anaemia in pregnancy. Clinical Haematology 1985;14:613-28.
39. Shushan A, Stemmer SM, Reubinoff BE, et al. Carcinoma of the colon during pregnancy. Obstet Gynecol Surv 1992;47:222-5.
40. Cohen AM, Tremiterra S, Candela F, et al. Prognosis of node-positive colon cancer. Cancer 1991;67:1859-61.
41. Rougier P, Ducreux M, Pignon JP, et al. Prognostic factors in patients with liver metastases from colorectal carcinoma treated with discontinuous intra-arterial hepatic chemotherapy. Eur J Cancer 1991;27:1226-30.
42. Seidel HM, Ball JW, Dains JE, et al. Mosby's guide to physical examination. 4th edition. St Louis: Mosby; 1999. p 234.
43. Levin B, Hess K, Johnson C. Screening for colorectal cancer: a comparison of 3 fecal occult blood tests. Arch Intern Med 1997;157:970-6.
44. Bond JH. Fecal occult blood testing for colorectal cancer: can we afford not to do this? Gastroenterol Clin North Am 1997;26:57-70.
45. Ahlquist DA. Fecal occult blood testing for colorectal carcinoma: can we afford to do this? Gastrointest Clin North Am 1997;26:41-55.
46. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
47. Greenberg PD, Cello JP, Rocked DC. Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease. Am J Med 1996;100:598-604.
48. Hardcastle JD, Chamberlin J, Sheffield J, et al. Randomized control trial of faecal occult blood screening for colorectal cancer: results for first 107,349 subjects. Lancet 1989;1:1160-4.
49. Allison JE, Tekawa IS, Ransom LJ, et al. A comparison of fecal occult blood tests for colorectal cancer screening. N Engl J Med 1996;334:155-9.
50. Mandel JS, Bond JH, Bradley N, et al. Sensitivity, specificity and positive predictivity of the hemoccult test in screening for colorectal cancers: the University of Minnesota's colon cancer control study. Gastroenterology 1989;97:597-600.
51. Allen LH. Nutritional supplementation for the pregnant woman. Clin Obstet Gynecol 1994;37:587-95.
52. Spratt JS, Spjut HJ. Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma. Cancer 1967;20:1976-85.
53. Mendenhall HW. Serum protein concentrations in pregnancy: I. concentrations in maternal serum. Am J Obstet Gynecol 1970;106:388-99.
54. Jonsson PE, Bengtsson G, Carlsson G, et al. Value of serum 5-nucleotidase, alkaline phosphatase and gamma-glutamyl transferase for prediction of liver metastases preoperatively in colorectal cancer. Acta Chir Scand 1984;150:419-23.
55. Pratt DS, Kaplan MM. Evaluation of the liver: A. laboratory tests. In: Schiff ER, Sorrell MF, Maddrey WC, editors. Diseases of the liver. 8th edition. Philadelphia: Lippincott-Raven; 1999. p 205-44.
56. Song CS, Kappas A. The influence of estrogens, progestins and pregnancy on the liver. Vitam Horm 1968;26:147-95.
57. Baker AL. Liver and biliary tract diseases. In: Barron WM, Lindheimer MD, Davidson JM, editors. Medical disorders during pregnancy. 2nd edition. St. Louis: Mosby; 1995. p 284-305.
58. Cunningham FG, Gant NF, Levano KJ, et al. Maternal adaptations to pregnancy: liver. In: Williams obstetrics. 21st edition. New York: McGraw-Hill; 2001. p 190.
59. Fishman WH. Immunologic and biochemical approaches to alkaline phosphatase isoenzyme analysis: the Regan isoenzyme. Ann N Y Acad Sci 1969;116:745-59.
60. Whitefield JB, Pounder RE, Neale G, et al. Serum gamma-glutamyl transpeptidase activity in liver disease. Gut 1972;13:702-8.
61. Moertel CG, Fleming TR, MacDonald JS, et al. Hepatic toxicity associated with fluorouracil plus levamisole adjuvant chemotherapy. J Clin Oncol 1993;11:2386-90.
62. Ledward RS. The management of puerperal hemorrhoids: a double-blind clinical trial of Anacal rectal ointment. Practitioner 1980;224:660-1.
63. Medich DS, Fazio VW, Hemorrhoids, anal fissure, and carcinoma of the colon, rectum, and anus during pregnancy. Surg Clin North Am 1995;75:77-88.
64. Riley CA, Portis MC. Pregnancy-related hepatic and gastrointestinal disorders. In: Feldman M, Sleisenger MH, Scharschmidt BF, editors. Gastrointestinal and liver disease: pathophysiology, diagnosis, management. 6th edition. Philadelphia: WB Saunders; 1998. p 1253-64.
65. Wald A, van Thiel DH, Hoechstetter L, et al. Effect of pregnancy on gastrointestinal transit. Dig Dis Sci 1982;27:1015-8.
66. Walker M, Sylvain J, Stern H. Bowel obstruction in a pregnant patient with ileal pouch-anal anastomosis. Can J Surg 1997;40:471-3.
67. Mashiach R, Kaplan B, Braslavsky D, et al. Carcinoma of the colon associated with high extragenital production of beta-hCG: a case report. Acta Obstet Scand 1995;74:845-8.
68. Waye JD, Williams CB. Colonoscopy and flexible sigmoidoscopy. In: Yamada T, Alpers DH, Owyang C, et al, editors. Textbook of gastroenterology. 3rd edition. Philadelphia: Lippincott, Williams & Wilkins; 1999. p 2701-17.
69. Cappell MS, Sidhom OA. A multicenter, multiyear study of the safety and clinical utility of flexible sigmoidoscopy in 24 consecutive patients with follow-up of fetal outcome. Dig Dis Sci 1995;40:472-9.
70. Boland CR. Malignant tumors of the colon. In: Yamada T, Alpers DH, Owyang C, et al. Textbook of gastroenterology. 3rd edition. Philadelphia: Lippincott, Williams & Wilkins; 1999. p 2023-82.
71. Carethers JM. The cellular and molecular pathogenesis of colorectal cancer. Gastroenterol Clin North Am 1996;25:737-54.
72. Vogelstein B, Kinzler KW. Colorectal cancer and the intersection between basic and clinical research. Cold Spring Harb Symp Quant Biol 1994;59:517-21.
73. Paridaens R, Sylvester RJ, Ferrazi E, et al. Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer. Cancer 1980;46:2889-95.
74. Budman DR, Citron ML. Adjuvant therapy for breast cancer. Clin Obstet Gynecol 1994;37:978-87.
75. Glick JH, Gelber RD, Goldhirsch A, et al. Meeting highlights: adjuvant therapy for primary breast cancer. J Natl Cancer Inst 1992;84:1479-85.
76. Francavilla A, Di Leo A, Polimeno L, et al. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. Gastroenterology 1987;93:1301-6.
77. Hendrickse CW, Jones CE, Donovan IA, et al. Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines. Br J Surg 1993;80:636-40.
78. Stedman KE, Moore GE, Mortan RT. Estrogen receptor proteins in diverse human tumors. Arch Surg 1980;115:244-8.
79. Xu X, Thomas ML. Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro. Mol Cell Endocrinol 1994;105:197-201.
80. Korenaga D, Orita H, Maekawa S, et al. Relationship between hormone receptor levels and cell-kinetics in human colorectal cancer. Hepatogastroenterolgy 1997;44:78-83.
81. Sica V, Papaleo G, Nola E, et al. Estrogen and progesterone receptors in colorectal cancer. In: Periti P, Grassi G, editors. Current chemotherapy and immunotherapy. Washington (DC): American Society of Microbiology; 1981. p 1564-6.
82. Dawson PM, Shousha S, Blair SD, et al. Oestrogen receptors in colorectal carcinoma. J Clin Pathol 1990;43:149-51.
83. D'Istria M, Fasano S, Catougno F, et al. Androgen and progesterone receptors in colonic and rectal cancers. Dis Colon Rectum 1986;29:263-5.
84. Ollayos CW, Riordan GP, Rushin JM. Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas, and lung. Arch Pathol Lab Med 1994;118:630-2.
85. Slattery ML, Samowitz WS, Holden JA. Estrogen and progesterone receptors in colon tumors. Am J Clin Pathol 2000;113:364-8.
86. Wobbes T, Beex LV, Koenders AM. Estrogen and progestin receptors in colon cancer? Dis Colon Rectum 1984;27:591-2.
87. Chute CG, Willett WC, Colditz GA, et al. A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology 1991;2:201-7.
88. Kvale G, Heuch I. Is the incidence of colorectal cancer related to reproduction? A prospective study of 63,000 women. Int J Cancer 1991;47:390-5.
89. Marcus PM, Newcomb PA, Young T, et al. The association of reproductive and menstrual characteristics and colon and rectal cancer risk in Wisconsin women. Ann Epidemiol 1995;5:303-9.
90. Devesa SS, Chow WH. Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 1993;71:3819-26.
91. Cooper HS, Slemmer JR. Surgical pathology of carcinoma of the colon and rectum. Semin Oncol 1991;18:367-80.
92. Fisher ER, Sass R, Palekar A, et al. Dukes' classification revisited: findings from the national surgical adjuvant breast and bowel projects (protocol R-01). Cancer 1989;64:2354-60.
93. De la Fontaine C, Frileux P, Berger A, et al. Digestive system cancers and pregnancy. Revue Francaise de Gynecologie et d'Obstetrique 1993;88:535-7.
94. Gonsoulin W, Mason B, Carpenter Jr. RJ. Colon cancer in pregnancy with elevated maternal alpha-fetoprotein level at presentation. Am J Obstet Gynecol 1990;163:1172-3.
95. Green CK, Harris RF, Massey FM. Cancer of the colon during pregnancy: a review of the literature and report of a case associated with ulcerative colitis. Obstet Gynecol 1975;46:480-3.
96. Heise RH, van Winter JT, Wilson TO, et al. Colonic cancer during pregnancy: case report and review of the literature. Mayo Clin Proc 1992;67:1180-1184.
97. Helou J, Nakhleh S, Shalev E, et al. Colonic carcinoma during pregnancy. Harefuah 1994;126:131-2.
98. Heres P, Wiltink J, Cuesta MA, et al. Colon carcinoma during pregnancy: a lethal coincidence. Europ J Obstet Gynecol Reprod Biol 1993;48:149-52.
99. Hill JA, Kassam SH, Talledo OE. Colonic cancer in pregnancy. South Med J 1984;77:375-8.
100. Jaffe R, Schwartz I, Freund U, et al. Perforated adenocarcinoma of the colon during pregnancy. Int J Gynaecol Obstet 1989;30:371-3.
101. Neal AJ, Oliver RT, Savage W. Accelerated malignant disease in pregnancy [letter]. Br J Clin Pract 1993;47:228.
102. Toan NN. Cancer of the colon and pregnancy: a new case. J Gynecol Obstet Biol Reprod (Paris) 1993;22:641-3.
103. Tsukamoto N, Uchino H, Matsukuma K, et al. Carcinoma of the colon presenting as bilateral ovarian tumors during pregnancy. Gynecol Oncol 1986;24:386-91.
104. Van Voorhis B, Cruikshank DP. Colon carcinoma complicating pregnancy: report of two cases. J Reprod Med 1989;34:923-7.
105. Vitoratos N, Louridas K, Zourlas PA. Carcinoma of the colon during pregnancy [letter]. Int J Gynaecol Obstet 1994;44:72-3.
106. Zakut H, Marmur G. Colon carcinoma in pregnancy: case report and review of literature. Clin Exp Obstet Gynecol 1984;11:27-31.
107. Shioda Y, Koizumi S, Furuya S, et al. Intussusception caused by a carcinoma of the cecum during pregnancy: report of a case and review of the literature. Surg Today 1993;23:556-61.
108. Bresalier RS, Ho SB, Schoeppner HL, et al. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastases. Gastroenterology 1996;110:1354-67.
109. Degiannis E, Sliwa K, Levy R, et al. Clinicopathological trends in colorectal carcinoma in a black South African population. Trop Gastroenterol 1995;16:55-61.
110. Griffin PM, Liff JM, Greenberg RS, et al. Adenocarcinomas of the colon and rectum in persons under 40 years old: a population-based study. Gastroenterology 1991;100:1033-40.
111. Shahrudin MD, Noori SM. Cancer of the colon and rectum in the first three decades of life. Hepatogastroenterology 1997;44:441-4.
112. Green JB, Timmcke AE, Mitchell WT, et al. Mucinous carcinoma: just another colon cancer? Dis Colon Rectum 1993;36:49-54.
113. Rothman LA, Cohen CJ, Astarloa J. Placental and fetal involvement by maternal malignancy: a report of rectal carcinoma and review of the literature. Am J Obstet Gynecol 1973;116:1023-34.
114. Secco GB, Fardelli R, Campora E, et al. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Oncology 1994;51:30-4.
115. Shepherd NA, Baxter KJ, Love SB. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997;112:1096-102.
116. Sugarbaker PH, Schellinx ME, Chang D, et al. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996;20:585-91.
117. Heys SD, Sherif A, Bagley JS, et al. Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg 1994;81:685-8.
118. Steinberg SM, Barwick KW, Stablein DM. Importance of tumor pathology and morphology in patients with surgically resected colon cancer: findings from the Gastrointestinal Tumor Study Group. Cancer 1986;58:1340-5.
119. Knoepp Jr. LF, Ray JE, Overby I. Ovarian metastases from colon carcinoma. Dis Colon Rectum 1973;16:305-11.
120. Mason MH, Kovalcik PJ. Ovarian metastases from colon carcinoma. J Surg Oncol 1981;17:33-8.
121. Pitluk H, Poticha SM. Carcinoma of the colon and rectum in patients less than 40 years of age. Surgery Gynecology and Obstetrics 1983;157:335-7.
122. Recalde M, Holyoke ED, Elias EG. Carcinoma of the colon, rectum, and anal canal in young patients. Surgery Gynecology and Obstetrics 1974;139:909-13.
123. Klein MD, Goodfriend MJ, Gordimer H. Adenocarcinoma of the colon with bilateral ovarian metastases: report of a case during pregnancy. Obstet Gynecol 1955;6:410-5.
124. Matsuyama T, Tsukamoto N, Matsukuma K, et al. Malignant ovarian tumors associated with pregnancy: report of six cases. Int J Gynaecol Obstet 1989;28:61-6.
125. Herrera-Ornelas L, Natarajan N, Tsukada Y, et al. Adenocarcinoma of the colon masquerading as primary ovarian neoplasia: an analysis of ten cases. Dis Colon Rectum 1983;26:377-80.
126. Dildy III GA, Moise KJ, Carpenter Jr. RJ, et al. Maternal malignancy metastatic to the products of conception: a review. Obstet Gynecol Surv 1989;44:535-40.
127. Rubin PH, Janowitz HD. The digestive tract and pregnancy. In: Cherry SH, Berkowitz RL, Kase NG, editors. Medical, surgical, and gynecologic complications of pregnancy. 3rd edition. Baltimore: Williams and Wilkins; 1985. p 196-206.
128. Lamerz R, Reuder H. Significance of CEA determination in patients with cancer of the colon-rectum and the mammary gland in comparison to physiological states in connection with pregnancy. Bull Cancer 1976;63:575-86.
129. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med 1986;104:66-73.
130. Moertel CG, O'Fallon JR, Go VLW, et al. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer 1986;58:603-10.
131. Arnaud JP, Koehl C, Adloff M. Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma. Dis Colon Rectum 1980;23:141-4.
132. Koch M, Washer G, Gaedke H, et al. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers. J Natl Cancer Inst 1982;69:813-5.
133. Bengtsson G, Carlsson G, Hafstrom L, et al. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981;141:586-9.
134. Balthazar EJ, Megibow AJ, Hulnick D, et al, Carcinoma of the colon: detection and preoperative staging by CT. AJR Am J Roentgenol 1991;156:909-15.
135. Isbister WH, al-Sanea O. The utility of pre-operative abdominal computerized tomography scanning in colorectal surgery. J R Coll Surg Edinb 1996;41:232-4.
136. Brent RL. Radiation teratogenesis. Teratology 1980;21:281-98.
137. Brent RL. The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol 1989;16:347-68.
138. Baillie J, Cairns SR, Cotton PB. Endoscopic management of choledocholithiasis during pregnancy. Surgery Gynecology and Obstetrics 1990;171:1-4.
139. Dick R. The liver and spleen. In: Sutton D, Whitehouse RW, Jenkins JPR, et al, editors. Textbook of radiology and imaging. 6th edition. New York: Churchill Livingstone; 1998. p 981-1028.
140. Nies C, Leppek R, Sitter H, et al. Prospective evaluation of different diagnostic techniques for the detection of liver metastases at the time of primary resection of colorectal carcinoma. Eur J Surg 1996;162:811-6.
141. Reece EA, Assimakopoulos E, Zheng XZ, et al. The safety of obstetric ultrasonography: concern for the fetus. Obstet Gynecol 1990;76:139-46.
142. Grant EG. Liver. In: Mittelstaedt CA, editor. General ultrasound. New York: Churchill Livingstone; 1992. p 173.
143. Ralls PW, Jeffrey Jr. RB, Kane RA. Ultrasonography. In: Yamada T, Alpers DH, Owyang C, et al., editors. Textbook of gastroenterology. 3rd edition. Philadelphia: Lippincott, Williams & Wilkins; 1999. p 2972-99.
144. Seidman DS, Heyman Z, Ben-Ari G, et al. Use of magnetic imaging in pregnancy to diagnose intussusception induced by colon cancer. Obstet Gynecol 1992;79:822-3.
145. Colletti PM, Sylvestre PB. Magnetic resonance imaging in pregnancy. Magn Reson Imaging Clin N Am 1994;2:291-307.
146. Elster AD. Does MR imaging have any known effects on the developing fetus? Am J Roentgenol 1994;162:1493.
147. Kanal E. Pregnancy and the safety of magnetic resonance imaging. Magn Reson Imaging Clin NAm 1994;2:309-17.
148. Collier BD. New radiographic techniques for colorectal cancer. Cancer 1993;71:4214-6.
149. Rummeny EJ, Wernecke K, Saini S, et al. Comparison between high-field-strength MR imaging and CT for screening of hepatic metastases: a receiver operating characteristic analysis. Radiology 1992;182:879-86.
150. Soyer P, Levesque M, Caudron C, et al. MRI of liver metastases from colorectal cancer versus CT during arterial portography. J Comput Assist Tomogr 1993;17:67-74.
151. Bernardino ME, Young SW, Lee JKT, et al. Hepatic MR imaging with MC-DPDP: safety, image quality, and sensitivity. Radiology 1992;183:53-8.
152. Fretz CJ, Stark DD, Metz CE, et al. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR Am J Roentgenol 1990;155:763-70.
153. Saini S, Edelman RR, Sharma P, et al. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). AJR Am J Roentgenol 1995;164:1147-52.
154. Garden AS, Griffiths RD, Weindling AM, et al. Fast-scan magnetic resonance imaging in fetal visualization. Am J Obstet Gynecol 1991;164:190-6.
155. Ward K. Genetics and prenatal diagnosis. In: Scott JR, DiSaia J, Hammond CB, et al, editors. Danforth's obstetrics and gynecology. 8th edition. Philadelphia: Lippincott, Williams & Wilkins; 1999. p 173-95.
156. Chu DZJ, Giacco G, Martin RG, et al. The significance of synchronous carcinoma and polyps in the colon and rectum. Cancer 1986;57:445-50.
157. Zauber AG, Winawer SJ. Initial management and follow-up surveillance of patients with colorectal adenomas. Gastroenterol Clin North Am 1997;26:85-101.
158. Koness RJ, King TC, Schecter S, et al. Synchronous colon carcinomas: molecular-genetic evidence for multicentricity. Ann Surg Oncol 1996;3:136-43.
159. Passman MA, Pommier RF, Vetto JT. Synchronous colon primaries have the same prognosis as solitary colon cancers. Dis Colon Rectum 1996;39:329-34.
160. Rex DK, Mark D, Clark B, et al. Colonoscopy evaluations: justification by cost? Am J Gastroenterol 1996;91:614-5.
161. Rex DK, Rahmani EY, Haseman JH, et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997;112:292-4.
162. Briggs GG, Freeman RK, Yaffe SJ. Diazepam. In: Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2002. p 390-6.
163. Cappell MS. The safety of gastrointestinal endoscopy in high risk patients. Dig Dis 1996;14:228-44.
164. Kuhnert BR, Linn PL, Kennard MJ, et al. Effects of low doses of meperidine on neonatal behavior. Anesth Analg 1985;64:335-42.
165. Melmed AP. Anesthesia principles and techniques in pregnancy. In: Cherry SH, Merkatz IR, editors. Complications of pregnancy: medical, surgical, gynecologic, psychosocial, and perinatal. 4th edition. Baltimore: Williams and Wilkins; 1991. p 732-64.
166. Cappell MS, Sidhom O, Colon V. A study at ten medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and eight colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig Dis Sci 1996;41:2353-60.
167. Frank B. Endoscopy in pregnancy. In: Karlstadt RG, Surawicz CM, Croitoru R, editors. Gastrointestinal disorders during pregnancy. Arlington, VA: American College of Gastroenterology, 1994. p 24-9.
168. Bashir RW, Montgomery EA, Gupta PK, et al. Massive gastrointestinal hemorrhage during pregnancy caused by ectopic decidua of the terminal ileum and colon. Am J Gastroenterol 1995;90:1325-7.
169. Rojansky N, Shushan A, Livni N, et al. Pregnancy associated with colon carcinoma overexpressing p53. Gynecol Oncol 1997;64:516-20.
170. Rosenberg L, Mitchell AA, Parsells JL, et al. Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med 1983;309:1282-5.
171. Safra MJ, Oakley Jr. GP. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 1975;2:478-80.
172. Safra MJ, Oakley Jr. GP. Valium: an oral cleft teratogen? Cleft Palate J 1976;13:198-200.
173. Briggs GG, Freeman RK, Yaffe SJ. Meperidine. In: Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2002. p 859-60.
174. Briggs GG, Freeman RK, Yaffe SJ. Midazolam. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2002. p 931-3.
175. Cunningham FG, Gant NF, Levano KJ, et al. Analgesia and anesthesia. In: Williams obstetrics. 21st edition. New York: McGraw-Hill; 2001. p 361-83.
176. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Boston: John Wright; 1977.
177. Belfrage P, Boreus LO, Hartvig P, et al. Neonatal depression after obstetrical analgesia with pethedine: the role of injection-delivery time interval and the plasma concentrations of pethidine and norpethidine. Acta Obstet Gynecol Scand 1981;60:43-8.
178. Morrison JC, Wiser WL, Rosser SI, et al. Metabolites of meperidine related to fetal depression. Am J Obstet Gynecol 1973;115:1132-7.
179. Dark DS, Campbell DR, Wesselius LJ. Arterial oxygen desaturation during gastrointestinal endoscopy. Am J Gastroenterol 1990;85:1317-21.
180. Hampton KK, Grant PJ, Primrose J, et al. Haemostatic responses and vasopressin release during colonoscopy in man. Clin Sci 1991;81:257-60.
181. McKee CC, Ragland JJ, Meyers JO. An evaluation of multiple clinical variables for hypoxia during colonoscopy. Surgery Gynecology and Obstetrics 1991;173:37-40.
182. Simon IB, Lewis RJ, Satava RM. A safe method for sedating and monitoring patients for upper and lower gastrointestinal endoscopy. Am Surg 1991;57:219-21.
183. Esposito TJ, Gens DR, Smith LG, et al. Trauma during pregnancy: a review of 79 cases. Arch Surg 1991;126:1073-8.
184. Esposito TJ. Trauma during pregnancy. Emerg Med Clin North Am 1994;12:167-99.
185. Cappell MS, Colon V, Sidhom OA. A study of eight medical centers of the safety and clinical efficacy of esophagogastroduodenoscopy in 83 pregnant females with follow-up of fetal outcome and with comparison to control groups. Am J Gastroenterol 1996;91:348-54.
186. Milsom JW, Graffner H. Intrarectal ultrasonography in rectal cancer staging and in the evaluation of pelvic disease: clinical uses of intrarectal ultrasound. Ann Surg 1990;212:602-6.
187. Kimmey MB, Vilmann P. Endoscopic ultrasonography. In: Yamada T, Alpers DH, Owyang C, et al, editors. Textbook of gastroenterology. 3rd editionPhiladelphia: Lippincott, Williams & Wilkins; 1999. p 3000-20.
188. Boyce GA, Sivak MV, Lavery IC, et al. Endoscopic ultrasound in the pre-operative staging of rectal carcinoma. Gastrointest Endosc 1992;38:468-71.
189. Herzog U, von Flue M, Tondelli P, et al. How accurate is endorectal ultrasound in the preoperative staging of rectal cancer? Dis Colon Rectum 1993;36:127-34.
190. Abrams B. Weight gain and energy intake during pregnancy. Clin Obstet Gynecol 1994;37:515-27.
191. Luke B. Nutritional influences on fetal growth. Clin Obstet Gynecol 1994;37:538-49.
192. Naeye RL, Blanc W, Paul C. Effects of maternal nutrition on the human fetus. Pediatrics 1973;52:494-503.
193. Daly JM, Redmond HP, Lieberman MD, et al. Nutritional support of patients with cancer of the gastrointestinal tract. Surg Clin North Am 1991;71:523-36.
194. DeWys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980;69:491-7.
195. Donaldson SS. Nutritional support as an adjuvant to radiation therapy. JPEN J Parenter Enteral Nutr 1984;8:302-9.
196. Scholl TO, Hediger ML. Anemia and iron-deficiency anemia: compilation of data on pregnancy outcome. Am J Clin Nutr 1994;59(Suppl):492-501.
197. Earl R, Woteki CE. Iron deficiency anemia: recommended guidelines for the prevention, detection, and management among U.S. children and women of childbearing age. Washington (DC): National Academy Press; 1993. p 11-25.
198. Buzby GP, Mullen JL, Matthews DL, et al. Prognostic nutritional index in gastrointestinal surgery. Am J Surg 1980;139:160-7.
199. Powell DW. Approach to the patient with diarrhea. In: Yamada T, Alpers DH, Owyang C, et al, editors. Textbook of gastroenterology. 3rd edition. Philadelphia: Lippincott, Williams & Wilkins; 1999. p 858-909.
200. Lee M, Feldman M. Nausea and vomiting. In: Feldman M, Sleisenger MH, Scharschmidt BF, editors. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 6th edition. Philadelphia: WB Saunders; 1998. p 117-27.
201. Arbman G, Nilsson E, Storgren-Fordell V, et al. A short diagnostic delay is more important for rectal than for colonic cancer. Europ J Surg 1996;162:899-904.
202. Cunningham FG, Gant NF, Levano KJ, et al. Cesarean section and postpartum hysterectomy. Williams obstetrics. 21st edition. New York: McGraw-Hill; 2001. p 537-63.
203. Parry BR, Tan BK, Chan WB, et al. Rectal carcinoma during pregnancy. Aust N Z J Surg 1994;64:618-20.
204. Bucciarelli RL. Neonataology in the United States: Scope and organization. In: Avery GB, Fletcher MA, MacDonald MG, editors. Neonatology: pathophysiology and management of the newborn. 5th edition. Philadelphia: Lippincott, Williams & Wilkins; 1999. p 15-34.
205. Fetus and Newborn Committee. Canadian Paediatric Society and Maternal-Fetal Medicine Committee, Society of Obstetricians and Gynaecologists of Canada. Management of the woman with threatened birth of an infant of extremely low gestational age. CMAJ 1994;151:547-53.
206. Walsh C, Fazio VW. Cancer of the colon, rectum, and anus during pregnancy: the surgeon's perspective. Gastroenterol Clin North Am 1998;27:257-67.
207. The SCOTIA Study Group. Single-stage treatment for malignant left-sided colonic obstruction: a prospective randomized clinical trial comparing subtotal colectomy with segmental resection following intraoperative irrigation. Br J Surg 1995;82:1622-7.
208. Lau PW, Lo CY, Law WL. The role of one-stage surgery in acute left-sided colonic obstruction. Am J Surg 1995;169:406-9.
209. Maher M, Caldwell MP, Waldron R, et al. Staged resection or primary anastomosis for obstructing lesions to the left colon. Ir Med J 1996;89:138-9.
210. Tan SG, Nambiar R. Resection and anastomosis of obstructed left colonic cancer: primary or staged? Aust New Zeal J Surg 1995;65:728-31.
211. Brant HA. Acute appendicitis in pregnancy. Obstet Gynecol 1967;29:130-8.
212. Saunders P, Milton PJD. Laparotomy during pregnancy: an assessment of diagnostic accuracy and fetal wastage. BMJ 1993;3:165-7.
213. Kort B, Katz VL, Watson WJ. The effect of nonobstetric operation during pregnancy. Surgery Gynecology and Obstetrics 1993;177:371-6.
214. Tamir IL, Bongard FS, Klein SR. Acute appendicitis in the pregnant patient. Am J Surg 1990;160:571-6.
215. Neuhoff D, Burke MS, Porreco RP. Cesarean birth for failed progress in labor. Obstet Gynecol 1989;73:915-20.
216. Rosenbaum CP. A review of chemotherapy for colorectal carcinoma. Practical Gastroenterology 1997;21:10-7.
217. Grage TB, Moss SE. Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospectively controlled randomized trial. Surg Clin North Am 1981;61:1321-9.
218. Higgins GA, Lee LE, Dwight RW, et al. The case for adjuvant 5-fluorouracil in colorectal cancer. Cancer Clin Trials 1978;1:35.
219. MacDonald JS. Adjuvant chemotherapy for colon cancer. CA Cancer J Clin 1997;47:243-56.
220. Moertel CG, Fleming TR, MacDonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995;122:321-6.
221. Moertel CG, Fleming TR, MacDonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
222. Moertel CG, Fleming TR, MacDonald JS, et al. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol 1995;13:2936-43.
223. Chabner BA, Ryan DP, Paz-Ares L, et al. Antineoplastic agents. In: Hardman JG, Limbird LE, Gillman AG, editors. Goodman and Gil man's the pharmacological basis of therapeutics. 10th edition. New York: McGraw-Hill; 2001. p 1389-459.
224. Boike GM, Deppe G, Young JD, et al. Chemotherapy in a pregnant rat model-5-fluorouracil: nonlinear kinetics and placental transfer. Gynecol Oncol 1989;34:191-4.
225. Shuey DL, Buckalew AR, Wilke TS, et al. Early events following maternal exposure to 5-fluorouracil lead to dysmorphology in cultured embryonic tissues. Teratology 1994;50:379-86.
226. Shuey DL, Setzer RW, Lau C, et al. Biological modeling of 5-fluorouracil developmental toxicity. Toxicology 1995;102:207-13.
227. Physician's Desk Reference. 56th edition. Montvale (NJ): Medical Economics; 2002.
228. Sommers GM, Kao MS. Using chemotherapeutic agents during pregnancy. Contemporary Obstetrics and Gynecology 1987;30:45-8.
229. Briggs GG, Freeman RK, Yaffe SJ. Fluorouracil. In: Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 6th editionPhiladelphia: Lippincott Williams & Wilkins; 2002. p 561-3.
230. Zemlickis D, Lishner M, Degendorfer P, et al. Fetal outcome after in vitro exposure to cancer chemotherapy. Arch Intern Med 1992;152:573-6.
231. Stephens JD, Golbus MS, Miller TR, et al. Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester. Am J Obstet Gynecol 1980;137:747-9.
232. Turchi JJ, Villasis C. Anthracyclines in the treatment of malignancy in pregnancy. Cancer 1988;61:435-40.
233. Berry DL, Theriault RL, Holmes FA, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999;17:855-61.
234. Giacalone PL, Laffargue F, Benos P. Chemotherapy for breast carcinoma during pregnancy: a French national survey. Cancer 1999;86:2266-72.
235. Cuvier C, Espie M, Extra JM, et al. Vinorelbine in pregnancy. Eur J Cancer 1997;33:168-9.
236. Stadler HE, Knowles J. Fluorouracil in pregnancy: effect on the neonate. JAMA 1971;217:214-5.
237. Muller T, Hofmann J, Steck T. Eclampsia after polychemotherapy for nodal-positive breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996;67:197-8.
238. Selevan SG, Lindbohm ML, Hornung RW, et al. A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N Engl J Med 1985;313:1173-8.
239. Song H, Wu P, Wang Y, et al. Pregnancy outcomes after successful chemotherapy for choriocarcinoma and invasive mole: long term follow-up. Am J Obstet Gynecol 1988;158:538-45.
240. Jeffrey LP, Chairman, National Study Commission on Cytotoxic Exposure. Position statement: The handling of cytotoxic agents by women who are pregnant, attempting to conceive, or breast feeding. January 12, 1987. As cited in: Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. Philadelphia: Lippincott, Williams and Wilkins; 2002. p. 343.
241. Skibber JM, Minsky BD, Hoff PM. Cancer of the colon. In: DeVita Jr. VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 6th edition. Philadelphia: Lippincott, Williams & Wilkins; 2001. p 1216-71.
242. Stevenson HC, Green I, Hamilton JM, et al. Levamisole: known effects on the immune system, clinical results and future applications to the treatment of cancer. J Clin Oncol 1991;9:2052-66.
243. Iida M, Taira N. Two cases of parafilariasis in dairy cattle and treatment of hemorrhage with levamisole topical application. J Vet Med Sci 1994;56:203-5.
244. Purswell BJ, Dawe DL, Brown J, et al. Effect of levamisole on immune function and reproductive performance in first-litter gilts. Am J Vet Res 1988;49:856-9.
245. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995;345:939-44.
246. O'Connell MJ, Mailliard JA, Kahn MJ, et al. Controlled trial of fluorouracil and low-dose leucovorin given for six months as post-operative adjuvant therapy for colon cancer. J Clin Oncol 1997;15:241-6.
247. Wolmark N, Rockette H, Mamounas EP, et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. J Clin Oncol 1999; 17:3553-9.
248. Hillman RS. Hematopoietic agents: growth factors, minerals, and vitamins. In: Hardman JG, Limbird LE, Gilman AG, editors. Goodman and Gilman's the pharmacological basis of therapeutics. 10th edition. New York: McGraw-Hill; 2001. p 1487-517.
249. Bower C, Stanley FJ. Dietary folate as a risk factor for neural tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989;150:613-9.
250. Laurence KM, James N, Miller MH, et al. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ 1981;282:1509-11.
251. Medical Research Council Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
252. American Hospital Formulary Service. Drug information 1997. Bethesda (MD): American Society of Health-System Pharmacists; 1997. p 2809-11.
253. Hill EP, Longo LD. Dynamics of maternal-fetal nutrient transfer. Federation Proceedings 1980;39:239-244.
254. Kaminetzky HA, Baker H, Frank O, et al. The effects of intravenously administered water-soluble vitamins during labor in normovitaminemic and hypovitaminemic gravidas on maternal and neonatal blood vitamin levels at delivery. Am J Obstet Gynecol 1974;120:697-703.
255. Czeizel AE, Dudas I, Metneki J. Pregnancy outcomes in a randomized controlled trial of periconceptional multivitamin supplementation: final report. Arch Gynecol Obstet 1994;255:131-9.
256. Centers for Disease Control. Use of folic acid for prevention of spina bifida and other neural tube defects: 1983-1991. MMWR Morb Mortal Wkly Rep 1991;40:513-6.
257. Glanville NT, Cook HW. Folic acid and prevention of neural tube defects. CMAJ 1992;146:39.
258. Leeming RJ, Blair JA, Brown SE. Vitamins to prevent neural tube defects [letter]. Lancet 1991;338:895.
259. Mukherjee MD, Sandstead HH, Ratnaparkhi MV, et al. Maternal zinc, iron, folic acid, and protein nutriture and outcome of human pregnancy. Am J Clin Nutr 1984;40:496-507.
260. Avrback P. Anencephaly associated with megavitamin therapy [letter]. CMAJ 1976;114:995.
261. Briggs GG, Freeman RK, Yaffe SJ. Folic acid. In: Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2002. p 583-97.
262. Tokunaga Y, Hata K, Nishitai R, et al. Postsurgical sequential methotrexate, fluorouracil, and leucovorin for advanced colorectal carcinoma: a preliminary study. J Surg Oncol 1997;66:45-50.
263. Schleuning M, Clemm C. Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy [letter]. N Engl J Med 1987;317:1666-7.
264. Briggs GG, Freeman RK, Yaffe SJ. Methotrexate. In: Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2002. p 893-7.
265. Okun DB, Groncy PK, Sieger L, et al. Acute leukemia in pregnancy: transient neonatal myelosuppression after combination chemotherapy in the mother. Med Pediatr Oncol 1979;7:315-9.
266. Pizzuto J, Aviles A, Noriega L, et al. Treatment of acute leukemia during pregnancy: presentation of nine cases. Cancer Treat Rep 1980;64:679-83.
267. Howard FM, Hill JM. Drugs in pregnancy. Obstet Gynecol Surv 1979;34:643-53.
268. Diaz-Canton EA, Pazdur R. Adjuvant medical therapy for colorectal cancer. Surg Clin North Am 1997;77:211-28.
269. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-15.
270. Laurie JA, Moertel CG, Fleming TR, et al. Surgical adjuvant therapy of large bowel carcinoma: an evaluation of levamisole and the combination of levamisole and 5-fluorouracil. J Clin Oncol 1989;7:1447-56.
271. Bruckner HW, Pittrelli J, Merrick M. Adenocarcinoma of the colon and rectum. In: Bast Jr. RC, Kufe DW, Pollock RE, et al. Cancer medicine. 5th edition. Hamilton (Ontario): BC Decker; 2000. p 1472-520.
272. Fleshman JW, Myerson RJ. Adjuvant radiation therapy for adenocarcinoma of the rectum. Surg Clin North Am 1997;77:15-25.
273. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985;312:1465-72.
274. Stockholm Rectal Cancer Study Group. Preoperative short-term radiation therapy in operable rectal carcinoma. Cancer 1990;66:49-55.
275. O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502-7.
276. Galland RB, Spencer J. The natural history of clinically established radiation enteritis. Lancet 1985;1:1257-8.
277. Committee on Biological Effects of Ionizing Radiation. National Research Council. Other somatic and fetal effects. In: Beir V, editor. Effects of low levels of ionizing radiation. Washington (DC): National Academy Press; 1990.
278. Hall EJ. Scientific view of low-level radiation risks. Radiographics 1991;11:509-18.
279. Mettler FA, Upton AC. Radiation exposure in utero. In: Medical effects of ionizing radiation. Philadelphia: WB Saunders; 1995. p 319-41.
280. Doll DC, Ringenberg S, Yarbro JW. Management of cancer during pregnancy. Arch Intern Med 1988;148:2058-64.
281. Mettler FA, Upton AC. Direct effects of radiation: reproductive organs. In: Medical effects of ionizing radiation. Philadelphia: WB Saunders; 1995. p 256-60.
282. Smith C, Butler JA. Colorectal cancer in patients younger than 40 years of age. Dis Colon Rectum 1989;32:843-6.
283. Antonelli NM, Dotters DJ, Katz VL, et al. Cancer in pregnancy: a review of the literature. Part, I. Obstet Gynecol Surv 1996;51:125-34.
284. Putzki PS, Scully JH, Kotz J, et al. Carcinoma of the colon producing acute intestinal obstruction during pregnancy. Am J Surg 1949;77:749-54.
285. Sachs BP, Penzias AS, Brown DAJ, et al. Cancer-related maternal mortality in Massachusetts, 1954-1985. Gynecol Oncol 1990;36:395-400.
286. Lewis BS, Swain P. Capsule endoscopy in the evaluation of patients with suspected small intestinal bleeding: the results of the first clinical trial [abstract]. Gastrointest Endosc 2001;53:AB70.
287. Rossini FP, Pennazio M, Santuri R, et al. Early experience with wireless capsule diagnostic endoscopy in patients with small bowel bleeding [abstract]. Am J Gastroenterol 2001;96:S111-2.
288. Schulmann K, Hollerbach S, Willert J, et al. Detection of occult gastrointestinal bleeding disorders by video capsule endoscopy (M2A) of the small bowel [abstract]. Gastroenterology 2002;122(Suppl):M1651.
289. Lewis BS. Complications and contraindications in capsule endoscopy [abstract]. Gastroenterology 2002;122(Suppl):M1656.
290. Ahlquist DA, Hara AK, Johnson CD. Computed tomographic colography and virtual colonoscopy. Gastrointest Endosc Clin North Am 1997;7:439-52.
291. Bond JH. Colorectal cancer screening: the potential role of virtual colonoscopy. J Gastroenterol 2002;37(Suppl):92-6.
292. Laghi A, Iannaccone R, Carbone I, et al. Computed tomographic colonography (virtual colonoscopy): blinded prospective comparison with conventional colonoscopy for the detection of colorectal neoplasia. Endoscopy 2002;34:441-6.
293. Rex DK. Barium studies/virtual colonoscopy: the gastroenterologist's perspective. Gastrointest Endosc 2002;55(Suppl):33-6.
294. Chung DC, Rustgi AK. DNA mismatch repair and cancer. Gastroenterology 1995;109:1685-99.
295. Ivanovich JL, Read TE, Ciske DJ, et al. A practical approach to familial and hereditary colorectal cancer. Am J Med 1999;107:68-77.
296. Ahlquist DA. Molecular stool screening for colorectal cancer: using DNA markers may be beneficial, but large scale evaluation is needed. BMJ 2000;321:254-5.
297. Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000;119:1219-27.
298. Dong SM, Traverso G, Johnson C, et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst 2001;93:858-65.
299. Atkin W, Martin JP. Stool DNA-based colorectal cancer detection: finding the needle in the haystack [editorial]. J Natl Cancer Inst 2001;93:798-9.
300. Ahlquist DA, Shuber AP. Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clin Chim Acta 2002;315:157-68.
301. Gocke CD, Benko FA, Kopreski MS, et al. P53 and APC mutations are detectable in the plasma and serum of patients with colorectal cancer (CRC) or adenomas. Ann N Y Acad Sci 2000;906:44-50.
302. Hibi K, Robinson CR, Booker S, et al. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 1998;58:1405-7.
303. Kolble K, Ullrich OM, Pidde H, et al. Microsatellite alterations in serum DNA of patients with colorectal cancer. Lab Invest 1999;79:1145-50.
304. Lauschke H, Caspari R, Friedl W, et al. Detection of APC and K-ras mutations in the serum of patients with colorectal cancer. Cancer Detect Prev 2001;25:55-61.
305. Fleshner P, Slater G, Aufses Jr. AH. Age and sex distribution of patients with colorectal cancer. Dis Colon Rectum 1989;32:107-11.
306. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy: The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81.
307. Willett WC, Stampfer MJ, Colditz GA, et al. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990;323:1664-72.
308. Fuchs CS, Giovannucci EL, Colditz GA, et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 1999;340:169-76.
309. Howe GR, Benito E, Castelleto R, et al. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst 1992;84:1887-96.
310. Bussey HJR. Familial polyposis coli. Baltimore: Johns Hopkins University Press: 1975.
311. Vasen FH, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-7.
312. Fuchs CS, Giovannucci EL, Colditz GA, et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994;331:1669-74.
313. Katzka I, Brody RS, Morris E, et al. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology 1983;85:22-9.
314. Ekbom A, Helmick C, Zack M, et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990;336:357-9.
315. Morson BC, Bussey HJR. Magnitude of risk for cancer in patients with colorectal adenomas. Br J Surg 1985;72(Suppl):S23-5.
316. Heald RJ. Synchronous and metachronous carcinoma of the colon and rectum. Ann R Coll Surg Engl 1990;72:172-4.
317. Eisen GM, Sandler RS. Are women with breast cancer more likely to develop colorectal cancer? Critical review and meta-analysis. J Clin Gastroenterol 1994;19:57-63.
318. Reimer RR, Hoover R, Fraumeni Jr. JF, et al. Second primary neoplasms following ovarian cancer. J Natl Cancer Inst 1978;61:1195-7.
319. Bergfeldt K, Einhorn S, Rosendahl I, et al. Increased risk of second primary malignancies in patients with gynecological cancer: a Swedish record-linkage study. Acta Oncol 1995;34:771-7.
320. Sandler RS, Sandler DP. Radiation-induced cancers of the colon and rectum: assessing the risk. Gastroenterology 1983;84:51-7.
321. Klein RS, Catalano MT, Edberg SC, et al. Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med 1979;91:560-2.
322. Azimuddin K, Khubchandani IT, Stasik JJ, et al. Neoplasia after ureterosigmoidostomy. Dis Colon Rectum 1999;42:1632-8.
323. Reid FD, Mercer PM, Harrison M, et al. Cholecystectomy as a risk factor for colorectal cancer: a meta-analysis. Scand J Gastroenterol 1996;31:160-9.